Structural, optical, biological and photocatalytic activities of platinum nanoparticles using salixtetraspeama leaf extract via hydrothermal and ultrasonic methods

Optik ◽  
2021 ◽  
pp. 167494
Author(s):  
D. Ramachandiran ◽  
M. Elangovan ◽  
K. Rajesh
Author(s):  
Saheb Ali ◽  
Kattakgoundar Govindaraj Sudha ◽  
Gopalu Karunakaran ◽  
Mariyappan Kowsalya ◽  
Evgeny Kolesnikov ◽  
...  

2017 ◽  
Vol 9 (11) ◽  
pp. 9996-10002 ◽  
Author(s):  
Tsukasa Mizutaru ◽  
Galina Marzun ◽  
Sebastian Kohsakowski ◽  
Stephan Barcikowski ◽  
Dachao Hong ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Jayshree Nellore ◽  
Cynthia Pauline ◽  
Kanchana Amarnath

Current discovery demonstrates the rapid formation of platinum nanoparticles using leaf extract of a neurobeneficial plant, Bacopa monnieri (BmE). The nanoparticles (BmE-PtNPs) were stabilized and then coated with varied phytochemicals present within the leaf extract. These nanoparticles demonstrated the same activity of Complex I, as that of oxidizing NADH to NAD+ using a spectrophotometric method. This suggests that BmE-PtNPs are a potential medicinal substance for oxidative stress mediated disease with suppressed mitochondrial complex I, namely, Parkinson's disease (PD). Hence, the neuroprotective potentials of the phytochemical coated nanoparticle were explored in 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine- (MPTP-)induced experimental Parkinsonism in zebrafish model. BmE-PtNPs pretreatment significantly reversed toxic effects of MPTP by increasing the levels of dopamine, its metabolites, GSH and activities of GPx, catalase, SOD and complex I, and reducing levels of MDA along with enhanced locomotor activity. Taken together, these findings suggest that BmE-PtNPs have protective effect in MPTP-induced neurotoxicity in this model of Parkinson's disease via their dual functions as mitochondrial complex I and antioxidant activity.


Sign in / Sign up

Export Citation Format

Share Document